|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S1
|
$117,999
|
$8,260
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S2
|
$60,000
|
$4,200
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S3
|
$125,625
|
$8,794
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S4
|
$200,000
|
$14,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-38S5
|
$250,000
|
$17,500
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
5P30CA016359-38
|
$2,600,006
|
$182,000
|
FUCHS, CHARLES
|
YALE UNIVERSITY
|
|
|
XLF in double-strand break repair and chemo/radiosensitization
|
5R01CA166264-05
|
$307,700
|
$307,700
|
POVIRK, LAWRENCE
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Workshop on Methods in Supportive Oncology Research
|
5R25CA181000-05
|
$303,240
|
|
TEMEL, JENNIFER
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
|
Wnt pathway dynamics in breast cancer metastasis
|
5K22CA207463-02
|
$188,042
|
|
ROARTY, KEVIN
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Wiskott-Aldrich syndrome protein (WASp) signaling in the oncogenesis of T cell lymphomas
|
1K08CA218460-01
|
$106,531
|
$53,266
|
MURGA-ZAMALLOA, CARLOS
|
UNIVERSITY OF MICHIGAN
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
2P30CA138292-09
|
$2,524,399
|
$403,904
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S1
|
$59,999
|
$9,600
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-09S2
|
$102,081
|
$16,333
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Web App Technology for Boys and Parents: Improving HPV Vaccine Uptake
|
5R01CA210125-03
|
$626,868
|
|
WOODALL, W
|
KLEIN BUENDEL, INC.
|
|
|
WDR5 as a Critical Co-Factor for MYC
|
5F31CA210429-03
|
$29,196
|
|
FOSHAGE, AUDRA
|
VANDERBILT UNIVERSITY
|
|
|
Washington University SPORE in Pancreatic Cancer
|
5P50CA196510-03
|
$2,300,000
|
|
HAWKINS, WILLIAM
|
WASHINGTON UNIVERSITY
|
|
|
WalkIT: Neighborhood walkability and moderation of adaptive walking interventions
|
5R01CA198915-04
|
$568,727
|
|
ADAMS, MARC
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
VU PREDICT
|
1U24CA220325-01A1
|
$664,613
|
|
MANNING, HENRY
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Vitamin D and Follicular Lymphoma
|
5R01CA214890-02
|
$615,082
|
|
FRIEDBERG, JONATHAN
|
UNIVERSITY OF ROCHESTER
|
|
|
Virus-targeted therapeutic for EBV-Associated Malignancies
|
5R44CA153474-03
|
$519,583
|
$519,583
|
PERRINE, SUSAN
|
PHOENICIA BIOSCIENCES, INC.
|
|
|
Viral priming and targeting NK cells against solid tumor malignancies
|
5R35CA197292-04
|
$796,220
|
|
MILLER, JEFFREY
|
UNIVERSITY OF MINNESOTA
|
|
|
Viral Oncology Training Grant
|
5T32CA009111-40
|
$391,340
|
|
CULLEN, BRYAN
|
DUKE UNIVERSITY
|
|
|
Video Informed Consent Tools to Improve Care for Patients With Advanced Pancreatic Cancer
|
5K07CA204201-02
|
$176,231
|
$176,231
|
ENZINGER, ANDREA
|
DANA-FARBER CANCER INST
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
3R01CA184456-02S2
|
$25,857
|
$8,533
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VDAC Regulation of Warburg Metabolism in Hepatocarcinoma
|
5R01CA184456-02
|
$341,981
|
$112,854
|
MALDONADO, EDUARDO
|
MEDICAL UNIVERSITY OF SOUTH CAROLINA
|
|
|
VCU Massey Cancer Center Support Grant
|
2P30CA016059-36
|
$2,164,167
|
$216,417
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S1
|
$124,341
|
$12,434
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
VCU Massey Cancer Center Support Grant
|
3P30CA016059-36S2
|
$19,990
|
$1,999
|
GINDER, GORDON
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
|
Variations in Needs after Colorectal Cancer Diagnosis
|
5R01CA181392-05
|
$497,934
|
|
BOEHMER, ULRIKE
|
BOSTON UNIVERSITY MEDICAL CAMPUS
|
|
|
Variant identification for cancer genomics
|
1R15CA220059-01A1
|
$447,460
|
|
GRIGORIEV, ANDREY
|
RUTGERS THE STATE UNIV OF NJ CAMDEN
|
|
|
Vangl Dependent PCP Signaling Mediates EMT Induced Cell Invasiveness
|
5F31CA210467-03
|
$39,076
|
|
VANDERVORST, KACEY
|
UNIVERSITY OF CALIFORNIA AT DAVIS
|
|
|
Vanderbilt Clinical Oncology Research Career Development Award
|
5K12CA090625-19
|
$961,183
|
|
RATHMELL, W
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Validation of a Room-Temperature Storage Technique for Plasma/Serum Biospecimens
|
5R33CA204510-03
|
$338,767
|
|
AKSAN, ALPTEKIN
|
UNIVERSITY OF MINNESOTA
|
|
|
Validation of a genomic signature that predicts for sub-optimal debulking of epithelial ovarian cancer
|
1R21CA218973-01A1
|
$203,042
|
$203,042
|
BIRRER, MICHAEL
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
|
|
Validating the eCyPA/CD147 signaling complex for myeloma therapy
|
5R01CA196783-04
|
$394,823
|
|
CARRASCO, RUBEN
|
DANA-FARBER CANCER INST
|
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$465,962
|
$465,962
|
Hodge, James
|
CCR (NCI)
|
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$465,962
|
$232,981
|
Hodge, James
|
CCR (NCI)
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S1
|
$125,000
|
$1,250
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-43S2
|
$31,772
|
$318
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
5P30CA014520-43
|
$4,288,496
|
$42,885
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
Utilizing Electronic Health Records to Measure and Improve Prostate Cancer Care
|
5R01CA183962-04
|
$603,232
|
|
HERNANDEZ-BOUSSARD, TINA
|
STANFORD UNIVERSITY
|
|
|
Utility of RAS mimetics to block oncogenic signaling in colorectal cancer
|
1R21CA227963-01
|
$221,198
|
|
REDDY, E
|
ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
|
|
|
USP22 Function in Advanced Prostate Cancer
|
5R01CA182569-04
|
$493,498
|
|
KNUDSEN, KAREN
|
THOMAS JEFFERSON UNIVERSITY
|
|
|
Using Stat3 Signaling Profiles to Understand Chemotherapy Resistance in AML
|
5R01CA175026-04
|
$379,294
|
$379,294
|
REDELL, MICHELE
|
BAYLOR COLLEGE OF MEDICINE
|
|
|
Using Second Harmonic Generation to Predict Metastatic Outcome in Colon Adenocarcinoma
|
1R21CA208921-01A1
|
$200,807
|
$200,807
|
BROWN, EDWARD
|
UNIVERSITY OF ROCHESTER
|
|
|
Using markers to improve pancreatic cancer screening and surveillance
|
5U01CA210170-03
|
$954,328
|
|
GOGGINS, MICHAEL
|
JOHNS HOPKINS UNIVERSITY
|
|
|
Using CRISPR/Cas9 to dissect the role of FUS-CHOP in tumor response to radiation therapy
|
5F30CA206424-03
|
$38,124
|
|
CHEN, MARK
|
DUKE UNIVERSITY
|
|
|
Using Context to Improve Implementation of Evidenced-based Interventions for Colorectal Cancer Screening in Rural Primary Care (Precise CRC)
|
5K07CA211971-02
|
$170,636
|
|
DAVIS, MELINDA
|
OREGON HEALTH & SCIENCE UNIVERSITY
|
|
|
Using Big Data to Estimate the Effects of Complex Cost-Sharing Rules on Colorectal Cancer Screening and Patient Health
|
5R21CA219229-02
|
$205,694
|
|
WHALEY, CHRISTOPHER
|
RAND CORPORATION
|
|
|
Using a Narrative-Based Approach to Reducing Indoor Tanning
|
1R21CA226133-01
|
$173,456
|
|
PAGOTO, SHERRY
|
UNIVERSITY OF CONNECTICUT STORRS
|
|
Total relevant funding to Chemotherapy for this search: $361,639,755
|
